Moreover, they showed the reduction of KRAS-dependent cancer cell proliferation via PI4KA inhibition as Compound 7 (C7, PMID: 24366037) or Simeprevir, an anti-Hepatitis C virus (known as PI4KA inhibitors) mislocalized KRAS from the PM, indicating the potentiality of these compounds to be repurposed towards anti-cancer drugs [47]. This evidence concerns the gene PI4KA and cancer.